[
  {
    "ts": null,
    "headline": "Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market",
    "summary": "NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIMI International Medical Inc. BIMI International Medical Inc.’s stock was suspended on August 22, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the Class A ordinary shares, unit, warrant of Slam Corp. Slam Corp.’s stock was suspended on August 27, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced",
    "url": "https://finnhub.io/api/news?id=c9adbf407646744b3b144266e6de802a3bcc9aadf376432e3e8f2bb591589d07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736547180,
      "headline": "Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market",
      "id": 132374438,
      "image": "https://media.zenfs.com/en/globenewswire.com/c870662b5d8053bb2dfb7f7795f63c9c",
      "related": "NDAQ",
      "source": "Yahoo",
      "summary": "NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIMI International Medical Inc. BIMI International Medical Inc.’s stock was suspended on August 22, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the Class A ordinary shares, unit, warrant of Slam Corp. Slam Corp.’s stock was suspended on August 27, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced",
      "url": "https://finnhub.io/api/news?id=c9adbf407646744b3b144266e6de802a3bcc9aadf376432e3e8f2bb591589d07"
    }
  },
  {
    "ts": null,
    "headline": "Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2024",
    "summary": "NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 31, 2024, short interest in 3,085 Nasdaq Global MarketSM securities totaled 12,137,206,474 shares compared with 11,912,589,852 shares in 3,063 Global Market issues reported for the prior settlement date of December 13, 2024. The end-of-December short interest represents 2.50 days compared with 2.65 days for the prior reporting period. Short interest in 1,643 securities on The Nasdaq Capital MarketSM totaled",
    "url": "https://finnhub.io/api/news?id=958e6645c43023b67a36f85ba937732bbc476fa21beb8e0b2daafdd1e2d97ee1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736543100,
      "headline": "Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 31, 2024",
      "id": 132371934,
      "image": "https://media.zenfs.com/en/globenewswire.com/61b33638d968f3a6be105dad87f65564",
      "related": "NDAQ",
      "source": "Yahoo",
      "summary": "NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 31, 2024, short interest in 3,085 Nasdaq Global MarketSM securities totaled 12,137,206,474 shares compared with 11,912,589,852 shares in 3,063 Global Market issues reported for the prior settlement date of December 13, 2024. The end-of-December short interest represents 2.50 days compared with 2.65 days for the prior reporting period. Short interest in 1,643 securities on The Nasdaq Capital MarketSM totaled",
      "url": "https://finnhub.io/api/news?id=958e6645c43023b67a36f85ba937732bbc476fa21beb8e0b2daafdd1e2d97ee1"
    }
  },
  {
    "ts": null,
    "headline": "Nasdaq price target raised to $84 from $83 at Raymond James",
    "summary": "Raymond James analyst Patrick O’Shaughnessy raised the firm’s price target on Nasdaq (NDAQ) to $84 from $83 and keeps an Outperform rating on the shares. The firm updated the company’s model ahead of the Q4 report. Despite Nasdaq having overpaid for recent acquisitions, the company has an “increasingly attractive financial technology software franchise that is paired with a remarkable growth story in Nasdaq’s index franchise,” the analyst tells investors in a research note. The firm still hs con",
    "url": "https://finnhub.io/api/news?id=d96c2896a43a4c26519e0350fafba3244f15a9f4b575857da92a097d94141d48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736513415,
      "headline": "Nasdaq price target raised to $84 from $83 at Raymond James",
      "id": 132368239,
      "image": "https://media.zenfs.com/en/tipranks_452/7f01f2b57128720bbd368bcb6051700e",
      "related": "NDAQ",
      "source": "Yahoo",
      "summary": "Raymond James analyst Patrick O’Shaughnessy raised the firm’s price target on Nasdaq (NDAQ) to $84 from $83 and keeps an Outperform rating on the shares. The firm updated the company’s model ahead of the Q4 report. Despite Nasdaq having overpaid for recent acquisitions, the company has an “increasingly attractive financial technology software franchise that is paired with a remarkable growth story in Nasdaq’s index franchise,” the analyst tells investors in a research note. The firm still hs con",
      "url": "https://finnhub.io/api/news?id=d96c2896a43a4c26519e0350fafba3244f15a9f4b575857da92a097d94141d48"
    }
  }
]